PFE Pfizer to All Time High

NYSE:PFE   Pfizer, Inc
If you haven`t bought at my first call, when PFE was $40:

Than you should know that Pfizer’s vaccine with BioNTech SE is on track to be the best-selling drug product on a yearly basis and received backing from a European regulatory panel on Thursday to expand its use into children as young as five.

Still low PE Ratio ( TTM ) 15.42
Decent Forward Dividend & Yield 1.56 (2.89%)

The stock jumped also on the promise of its antiviral pill!

For me is a Buy even at this level!


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.